Skip to main content

National Healthcare Properties, Inc.

For the period ended Dec 31, 2025. Filed Feb 20, 2026.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Feb 20, 2026

NHPBP$25.44+0.0%Stored close · as of Oct 5, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Consolidated Balance Sheets as of December 31, 202 and

CONSOLIDATED BALANCE SHEETS

(In thousands, except share and per share data)

December 31,
20252024
ASSETS
Real estate investments, at cost:
Land$174,535$190,082
Buildings, fixtures and improvements1,785,9522,012,401
Acquired intangible assets246,544284,447
Construction in progress2,9947,867
Total real estate investments, at cost2,210,0252,494,797
Less: accumulated depreciation and amortization(691,200)(725,831)
Total real estate investments, net1,518,8251,768,966
Cash and cash equivalents57,62021,652
Restricted cash50,83252,443
Derivative assets, at fair value56919,206
Straight-line rent receivable, net21,48622,841
Operating lease right-of-use assets7,3777,480
Prepaid expenses and other assets, net23,01926,316
Accounts receivable, net9,2525,850
Deferred costs, net22,79221,269
Total assets$1,711,772$1,946,023
LIABILITIES AND EQUITY
Liabilities
Mortgage notes payable, net$367,629$779,160
Fannie Mae and other secured debt334,739362,216
Revolving credit facility186,000—
Term loan, net148,405—
Market lease intangible liabilities, net4,8516,125
Derivative liabilities, at fair value188—
Accounts payable and accrued expenses44,38189,575
Operating lease liabilities8,4678,109
Deferred rent9,2477,217
Distributions payable3,3403,496
Total liabilities1,107,2471,255,898
Commitments and Contingencies
Equity
7.375% Series A cumulative redeemable perpetual preferred stock, $0.01 par value, 4,608,371 and 4,740,000 authorized as of December 31, 2025 and 2024, respectively; 3,845,515 and 3,977,144 issued and outstanding as of December 31, 2025 and 2024, respectively3840
7.125% Series B cumulative redeemable perpetual preferred stock, $0.01 par value, 3,466,656 and 3,680,000 authorized as of December 31, 2025 and 2024, respectively; 3,416,656 and 3,630,000 issued and outstanding as of December 31, 2025 and 2024, respectively3536
Common stock, 0.01 par value, 300,000,000 shares authorized; 28,426,694 and 28,296,439 shares issued and outstanding as of December 31, 2025 and 2024, respectively1,1321,132
Additional paid-in capital2,531,3152,533,706
Accumulated other comprehensive income5,60416,640
Distributions in excess of accumulated earnings(1,938,060)(1,866,994)
Total stockholders’ equity600,064684,560
Non-controlling interests4,4615,565
Total equity604,525690,125
Total liabilities and equity$1,711,772$1,946,023
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.